BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16762630)

  • 1. HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.
    Shin SM; Chung YJ; Oh ST; Jeon HM; Hwang LJ; Namkoong H; Kim HK; Cho GW; Hur SY; Kim TE; Lee YS; Park YG; Ko J; Kim JW
    Gastroenterology; 2006 Jun; 130(7):2074-86. PubMed ID: 16762630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
    Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
    Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression.
    Cho GW; Shin SM; Namkoong H; Kim HK; Ha SA; Hur SY; Kim TE; Chai YG; Kim JW
    Gene; 2006 Dec; 384():18-26. PubMed ID: 16949218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
    Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
    Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HCCR oncoprotein as a biomarker for human breast cancer.
    Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW
    Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.
    Ko J; Shin SM; Oh YM; Lee YS; Ryoo ZY; Lee YH; Na DS; Kim JW
    Oncogene; 2004 Mar; 23(10):1950-3. PubMed ID: 14691448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCCRBP-3 induces tumorigenesis through direct interaction with HCCR-1 in human cancers.
    Ha SA; Kim HK; Yoo JA; Kim S; Shin SM; Gong GH; Lee YK; Kim JW
    Mol Carcinog; 2014 Jan; 53(1):30-7. PubMed ID: 22851403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCCRBP-1 directly interacting with HCCR-1 induces tumorigenesis through P53 stabilization.
    Ha SA; Shin SM; Lee YJ; Kim S; Kim HK; Namkoong H; Lee H; Lee YS; Cho YS; Park YG; Jeon HM; Oh C; Kim JW
    Int J Cancer; 2008 Feb; 122(3):501-8. PubMed ID: 17943721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1.
    Ruan WJ; Lin J; Xu EP; Xu FY; Ma Y; Deng H; Huang Q; Lv BJ; Hu H; Cui J; Di MJ; Dong JK; Lai MD
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):929-32. PubMed ID: 17048309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
    Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
    Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
    Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
    Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.
    Sagiv E; Memeo L; Karin A; Kazanov D; Jacob-Hirsch J; Mansukhani M; Rechavi G; Hibshoosh H; Arber N
    Gastroenterology; 2006 Aug; 131(2):630-9. PubMed ID: 16890615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells.
    Wang X; Wang J; Lin S; Geng Y; Wang J; Jiang B
    J Exp Clin Cancer Res; 2008 Sep; 27(1):44. PubMed ID: 18811981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
    Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
    Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.
    Kim MY; Yim SH; Kwon MS; Kim TM; Shin SH; Kang HM; Lee C; Chung YJ
    Gastroenterology; 2006 Dec; 131(6):1913-24. PubMed ID: 17087931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.